Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ENOS anticorps

NOS3 Reactivité: Humain ELISA, IHC Hôte: Souris Monoclonal 6H2 unconjugated
N° du produit ABIN969097
  • Antigène Voir toutes ENOS (NOS3) Anticorps
    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
    Reactivité
    • 273
    • 153
    • 151
    • 13
    • 10
    • 8
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 278
    • 29
    • 1
    Souris
    Clonalité
    • 280
    • 28
    Monoclonal
    Conjugué
    • 118
    • 25
    • 17
    • 14
    • 10
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    Cet anticorp ENOS est non-conjugé
    Application
    • 254
    • 104
    • 97
    • 91
    • 78
    • 53
    • 37
    • 25
    • 25
    • 25
    • 12
    • 8
    • 7
    • 4
    • 3
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC)
    Purification
    purified
    Immunogène
    Purified recombinant fragment of human eNOS expressed in E. coli.
    Clone
    6H2
    Isotype
    IgG1
    Top Product
    Discover our top product NOS3 Anticorps primaire
  • Indications d'application
    ELISA: 1:10000, IHC: 1:200 - 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    4°C, -20°C for long term storage
  • Moreno: "Genetic polymorphisms and haplotypes of eNOS in breast cancer." dans: Breast cancer research and treatment, Vol. 109, Issue 1, pp. 181-2, (2008) (PubMed).

    Lahiri, Martin: "Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line." dans: Oncology reports, Vol. 12, Issue 5, pp. 1007-11, (2004) (PubMed).

  • Antigène
    ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
    Autre désignation
    eNOS (NOS3 Produits)
    Synonymes
    anticorps ECNOS, anticorps eNOS, anticorps 2310065A03Rik, anticorps Nos-3, anticorps ecNOS, anticorps EC-NOS, anticorps NOSIII, anticorps cNOS, anticorps NOS, anticorps NOS3, anticorps eNos, anticorps ENOS, anticorps nitric oxide synthase 3, anticorps nitric oxide synthase 3, endothelial cell, anticorps NOS3, anticorps Nos3, anticorps nos3
    Sujet

    Description: Endothelial nitric-oxide synthase (eNOS), also known as NOS3, it is an important enzyme in the cardiovascular system. It is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm.

    Aliases: ECNOS, NOS3

    Poids moléculaire
    133 kDa
    ID gène
    4846
    HGNC
    4846
    Pathways
    ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Vous êtes ici:
Support technique